Ana Blazquez
Grupo de investigación
- Psiquiatría y psicología infantil y adolescente Post-doctoral researcher (R2A)
Publicaciones destacadas
-
Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine
Autores: Gassó P; Rodríguez N; Boloc D; Blázquez A; Torres T; Gortat A; Plana M; Lafuente A; Mas S; Arnaiz J; Lázaro L.Referencia: Progress In Neuro-Psychopharmacology & Biological Psychiatry 2017. -
Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine
Autores: Gassó P, Rodríguez N, Blázquez A, Monteagudo A, Boloc D, Plana MT, Lafuente A, Lázaro L, Arnaiz JA, Mas S .Referencia: Progress In Neuro-Psychopharmacology & Biological Psychiatry 2017. -
EPIGENETIC AND GENETIC VARIANTS IN THE HTR1B GENE AND CLINICAL IMPROVEMENT IN CHILDREN AND ADOLESCENTS TREATED WITH FLUOXETINE
Autores: Gasso, P.; Rodriguez, N.; Blazquez, A.; Monteagudo, A.; Boloc, D.; Plana, M. T.; Lafuente, A.; Lazaro, L.; Arnaiz, J. A.; Mas, S.;.Referencia: Basic & Clinical Pharmacology & Toxicology 2017. -
ASSOCIATION OF REGULATORY TPH2 POLYMORPHISMS WITH HIGHER REDUCTION IN DEPRESSIVE SYMPTOMS IN CHILDREN AND ADOLESCENTS TREATED WITH FLUOXETINE
Autores: Torres, T.; Gasso, P.; Rodriguez, N.; Boloc, D.; Blazquez, A.; Gortat, A.; Plana, M. T.; Lafuente, A.; Mas, S.; Lazaro, L.;.Referencia: Basic & Clinical Pharmacology & Toxicology 2017. -
Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: impact of the serotonin pathway
Autores: Mas S, Blázquez A, Rodríguez N, Boloc D, Lafuente A, Arnaiz JA, Lázaro L, Gassó P .Referencia: Pharmacogenetics And Genomics 2016. -
One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms
Autores: Blazquez, A.; Gasso, P.; Mas, S.; Plana, M. T.; Lafuente, A.; Lazaro, L.;.Referencia: Pharmacopsychiatry 2016. -
Differences in Psychopathology Between Immigrant and Native Adolescents Admitted to a Psychiatric Inpatient Unit
Autores: Blazquez, A; Castro-Fornieles, J; Baeza, I; Morer, A; Martinez, E; Lazaro, L.Referencia: Journal Of Immigrant And Minority Health 2015. -
Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients
Autores: Gasso, P; Rodriguez, N; Mas, S; Pagerols, M; Blazquez, A; Plana, M T; Torra, M; Lazaro, L; Lafuente, A.Referencia: Pharmacogenomics Journal 2014. -
Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder
Autores: Blazquez, Ana; Mas, Sergi; Plana, Maria Teresa; Gasso, Patricia; Mendez, Iria; Torra, Merce; Arnaiz, Joan Albert; Lafuente, Amalia; Lazaro, Luisa.Referencia: Journal Of Clinical Psychopharmacology 2014. -
Fluoxetine pharmacogenetics in child and adult populations
Autores: Blazquez, Ana; Mas, Sergi; Teresa Plana, MA; Lafuente, Amalia; Lazaro, Luisa.Referencia: European Child & Adolescent Psychiatry 2012.
Proyectos destacados
-
5TA-B-001, lnternational, multicentric, observational study to characterize the clinical subpopulations of patients with ASD.
Duración: 01/01/2023 -
pM21/00051, Estudio integrat devariación genética y motecutar de una cohorte españota de autismo y diseño de atgoritmos de diagnóstico genético y de biotipos terapéuticos.Cohorte ESTEA
Duración: 02/02/2022 -
AP171442019, Caracterización gen REPS2 como nuevo gen candidato para los trastornos del neurodesarrollo.
Duración: 10/09/2019 -
15300, European Autism lnterventions - a Multicentre Study for Developing New Medications (EU-AIMS-2-Trials)
Duración: 12/10/2018